Notice of Closed Meeting, 61752 [2020-21604]
Download as PDF
<![CDATA[
61752
Federal Register / Vol. 85, No. 190 / Wednesday, September 30, 2020 / Notices
Jeffery M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–21621 Filed 9–29–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
DD21–001, Study to Explore Early
Development (SEED) Follow up Studies.
Date: January 12–13, 2021.
Time: 10:00 a.m.–6:00 p.m., EST.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact: Jaya
Raman Ph.D., Scientific Review Officer,
CDC, 4770 Buford Highway, Mailstop
S107–8, Atlanta, Georgia 30341,
Telephone: (770) 488–6511, JRaman@
cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–21604 Filed 9–29–20; 8:45 am]
decision concerning the collection of
information between 30 and 60 days
after publication of this document in the
Federal Register. Therefore, a comment
is best assured of having its full effect
if OMB receives it within 30 days of
publication.
Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
ADDRESSES:
SUPPLEMENTARY INFORMATION:
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review; National
Advisory Committee on the Sex
Trafficking of Children and Youth in
the United States (NAC)
Recommendations and State SelfAssessment Survey (NEW)
Office on Trafficking in
Persons, Administration for Children
and Families, HHS.
ACTION: Request for public comment.
AGENCY:
The Office on Trafficking in
Persons (OTIP), Administration for
Children and Families (ACF), U.S.
Department of Health and Human
Services (HHS), is proposing to collect
data for a new survey, the National
Advisory Committee on the Sex
Trafficking of Children and Youth in the
United States (NAC) Recommendations
and State Self-Assessment Survey.
DATES: Comments due within 30 days of
publication. OMB is required to make a
SUMMARY:
Description: The Preventing Sex
Trafficking and Strengthening Families
Act of 2014 mandated the NAC to
develop a report describing how each
state and territory has implemented its
recommendations to address sex
trafficking in children and youth. The
NAC proposes to administer a survey
allowing states to assess their progress
in implementing NAC
recommendations. Submissions will
allow states to document their efforts in
the following sections:
Multidisciplinary Response, Screening
and Identification, Child Welfare,
Service Provision, Housing, Law
Enforcement and Prosecution, Judiciary,
Demand Reduction, Prevention,
Legislation and Regulation, Research
and Data, and Funding. Each state will
have the opportunity to provide a selfassessed tier ranking for each
recommendation, a justification of their
assessment, sources for their
assessment, and the public or private
nature of those sources.
Respondents: State Governors, Child
Welfare Agencies, Local Law
Enforcement, and Other Local Agencies.
Annual Burden Estimates:
ESTIMATED OPPORTUNITY COSTS FOR RESPONDENTS
Instrument
Total number
of respondents
contributing for
50 states
Total number of
responses per
respondent
250
1
jbell on DSKJLSW7X2PROD with NOTICES
NAC Recommendations and State Self-Assessment Survey .......................
Estimated Total Annual Burden
Hours: 1,713.
VerDate Sep<11>2014
17:36 Sep 29, 2020
Jkt 250001
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
E:\FR\FM\30SEN1.SGM
30SEN1
Average
burden hours
per response
6.85
Total/annual
burden hours
1,713
]]>Agencies
[Federal Register Volume 85, Number 190 (Wednesday, September 30, 2020)]
[Notices]
[Page 61752]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-21604]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Director, Strategic
Business Initiatives Unit, Office of the Chief Operating Officer, CDC,
pursuant to Public Law 92-463. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)--DD21-001, Study to Explore Early
Development (SEED) Follow up Studies.
Date: January 12-13, 2021.
Time: 10:00 a.m.-6:00 p.m., EST.
Place: Teleconference.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Jaya Raman Ph.D., Scientific
Review Officer, CDC, 4770 Buford Highway, Mailstop S107-8, Atlanta,
Georgia 30341, Telephone: (770) 488-6511, [email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-21604 Filed 9-29-20; 8:45 am]
BILLING CODE 4163-18-P
